Sorrento Therapeutics发布针对新冠病毒的蛋白酶抑制剂
Sorrento Therapeutics(SRNE.US)发布针对新冠病毒的蛋白酶抑制剂
智通财经APP获悉，Sorrento Therapeutics Inc (NASDAQ:SRNE)发布了一种针对SARS-CoV-2（新型冠状病毒）MPro蛋白酶的抑制剂–MPI8。该抑制剂对MPro和Cathepsin L都具有强力的抑制能力。其中Cathepsin L是SARS-CoV-2进入宿主细胞的关键宿主酶。而MPro则是病毒在入侵宿主细胞、自我复制时的关键蛋白酶。
据了解，这种新型的蛋白酶抑制剂已经过系统地评估并已进入到临床试验前的最后阶段。Sorrento董事长兼首席执行官Henry Ji表示:“公司致力于创造出一种可以应对新冠病毒经‘突变’而产生新的变种的治疗药物。
More Stories
Oil inches higher as Middle East tensions heat up
© Reuters. Army soldier miniatures and stock graph are seen in this illustration taken October 9, 2023. REUTERS/Dado Ruvic/Illustration/File Photo...
Asian stocks rise before US CPI; Japan’s Nikkei extends rally
. JP225 +1.88% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully to: + Add another position...
SEC approves spot Bitcoin ETFs
. SEC approves spot bitcoin ETFs BTC/USD +1.76% Add to/Remove from Watchlist Add to Watchlist Add Position Position added successfully...
Google lays off hundreds in Assistant, hardware, engineering teams
© Reuters. The Google logo is seen on the Google house at CES 2024, an annual consumer electronics trade show,...
Amazon has not offered remedies to EU concerns over iRobot deal
© Reuters. FILE PHOTO: The logo of Amazon is seen at the company's logistics centre in Boves, France, October 6,...
Stocks climb as megacaps lead; inflation data, earnings on deck
© Reuters. FILE PHOTO: People walk around the Financial District near the New York Stock Exchange (NYSE) in New York,...